Construction and validation of an educational technology on human papillomavirus vaccine for adolescents

ABSTRACT Objective: To construct and validate a comic-type educational technology on the human papillomavirus vaccine. Methods: A methodological study developed based on the manuals, informative notes of the Ministry of Health and with the suggestions of the target audience. Content validation was performed with 11 expert judges and the validation of appearance, with 32 adolescents. For the judges, the Content Validity Index was used and for the target audience the proportion of agreement was considered. Results: The comic book obtained a content validation index total of 0.95, a validation index considered adequate. It was identified a concordance greater than 0.80 in the validation of appearance with the target public, indicating an excellent degree of agreement. Conclusion: The technology was considered valid by the judges and the target audience, and can be used as an educational tool to guide the practice in the acceptability scenario of the vaccine. Implications for practice: The technology may contribute to the stimulation of adhesion to the human papillomavirus vaccine, since, in Brazil, the rates of adhesion to this vaccine are still low.

Download Full-text

Use of multimedia as an educational tool to improve human papillomavirus vaccine acceptability—A pilot study

Gynecologic Oncology ◽

10.1016/j.ygyno.2010.04.010 ◽

2010 ◽

Vol 118 (2) ◽

pp. 103-107 ◽

Cited By ~ 12

Author(s):

Eloise Chapman ◽

Pavithra Venkat ◽

Emily Ko ◽

Jorge P. Orezzoli ◽

Marcela Del Carmen ◽

...

Keyword(s):

Human Papillomavirus ◽

Pilot Study ◽

Educational Tool ◽

Human Papillomavirus Vaccine ◽

Vaccine Acceptability ◽

Papillomavirus Vaccine

Download Full-text

Human medicines European public assessment report (EPAR): Cervarix, human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Immunization, Date of authorisation: 20/09/2007, Revision: 32, Status: Authorised

Case Medical Research ◽

10.31525/cmr-145d596 ◽

2019 ◽

Author(s):

Keyword(s):

Human Papillomavirus ◽

Cervical Dysplasia ◽

Human Papillomavirus Vaccine ◽

Papillomavirus Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Papillomavirus Vaccine ◽

Uterine Cervical Dysplasia

Download Full-text

Vaccine Hesitancy and Differential Susceptibility to Media Coverage: A Critical Documentary Led to Substantial Reductions in Human Papillomavirus Vaccine Uptake in Denmark

Medical Decision Making ◽

10.1177/0272989x211003589 ◽

2021 ◽

pp. 0272989X2110035

Author(s):

Maria Knoth Humlum ◽

Niels Skipper ◽

Peter Rønø Thingholm

Keyword(s):

Human Papillomavirus ◽

Hpv Vaccine ◽

Media Coverage ◽

Differential Susceptibility ◽

Vaccine Uptake ◽

Vaccine Hesitancy ◽

Human Papillomavirus Vaccine ◽

Policy Makers ◽

Quasi Experimental ◽

Papillomavirus Vaccine

Objectives To investigate whether negative media coverage of the human papillomavirus (HPV) vaccine led to a decrease in the uptake of the first dose of the HPV vaccine (HPV1) in Denmark and, importantly, whether some groups of individuals were more susceptible to negative media coverage. Methods We measured HPV vaccine uptake of 12-year-old girls born in 2001 to 2004 using Danish administrative data. A quasi-experimental design was employed to assess whether a documentary that was critical of the HPV vaccine and aired in March 2015 affected HPV uptake. Results The documentary led to a quick and substantial decrease in the monthly propensity to vaccinate, which dropped 3 percentage points—or about 50%—in response to the documentary. Responses differed substantially across subgroups, and girls from families with high socioeconomic status (SES) were more susceptible to the negative media coverage. Conclusions Susceptibility to negative media coverage varied substantially across subgroups, highlighting the need for policy makers to appropriately target and differentiate initiatives to improve vaccine compliance rates.

Download Full-text